GOLD
GOLD ๋“ฑ๊ธ‰์˜ ํŒ๋งค์ž ์ž๋ฃŒ

์ ฟ’๋‚˜ํŠธ๋ฅจํ˜ˆ์ฆ(Hyponatremia)

"์ ฟ’๋‚˜ํŠธ๋ฅจํ˜ˆ์ฆ(Hyponatremia)"์— ๋Œ€ํ•œ ๋‚ด์šฉ์ž…๋‹ˆ๋‹ค.
8 ํŽ˜์ด์งฟ’
ํ•œ์้œ์˜คํ”ผ์Šค
์ตœ์ดˆ๋“ฑ๋ก์ผ 2025.03.13 ์ตœ์ข…์ ฟ’์ž‘์ผ 2025.03
8P ๋ฏธ๋้ฉ๋ณด๊ธฐ
์ ฟ’๋‚˜ํŠธ๋ฅจํ˜ˆ์ฆ(Hyponatremia)
  • ๋ณธ ๋ฌธ์„œ๋Š” ํ•œ๊ธ€ํ‘œ์ค€๋ฌธ์„œ(*.hwpx)๋กœ ์ž‘์„ฑ๋˜์—ˆ์Šต๋‹ˆ๋‹ค. ์ตœ์‹ ํŒจ์น˜๊ฐ€ ๋˜์–ด ์žˆ๋Š” 2010 ์ด์ƒ ๋ฒ„์ „์ด๋‚˜ ํ•œ๊ธ€๋ทฐ์–ด์—์„œ ํ™•์ธํ•ด ์ฃผ์‹œ๊ธฐ ๋ฐ”๋ž๋‹ˆ๋‹ค.

    ๋ฏธ๋้ฉ๋ณด๊ธฐ

    ๋ชฉ์ฐจ

    1. ์„œ๋ก 
    1) ์ •์˜์™ฟ’ ํŠน์ง•
    2) ์›์ธ
    3) ์ฆ์ƒ
    4) ์ง„๋‹จ ๋ฐฉ๋ฒ•

    2. ๋ณธ๋ก 
    1) ๋ณ‘ํƒœ์ƒ๋ฆฌ
    2) ํ•ฉ๋ณ‘์ฆ
    3) ์น˜๋ฃŒ ๋ฐฉ๋ฒ•
    4) ํ™˜์ž์˜ ๊ฐ„ํ˜ธ์ค‘์žฌ

    3. ๊ฒฐ๋ก 
    1) ํ™˜์ž ๊ฐ„ํ˜ธ์˜ ์ค‘์š”์„ฑ
    2) ํ™˜์ž ๊ฐ„ํ˜ธ์˜ ์‹ค์ œ์™ฟ’ ๊ณ ์ฐฐ
    3) ํ™˜์ž ๊ฐ„ํ˜ธ์— ๋Œ€ํ•œ ์ œ์–ธ

    4. ์ฐธ๊ณ ๋ฌธํ—Œ

    ๋ณธ๋ๅฉ๋‚ด์šฉ

    1) ์ •์˜์™ฟ’ ํŠน์ง•
    ์ ฟ’๋‚˜ํŠธ๋ฅจํ˜ˆ์ฆ(Hyponatremia)์€ ํ˜ˆ์ฒญ ๋‚˜ํŠธ๋ฅจ(Naโบ) ๋†๋„๊ฐ€ ์ •์ƒ ๋ฒ”์œ„(135~145 mEq/L)๋ณด๋‹ค ๋‚ฎ์•„ 135 mEq/L ์ดํ•˜๋กœ ๊ฐ์†Œํ•œ ์ƒํƒœ๋ฅผ ์˜๋ฏธํ•œ๋‹ค. ๋‚˜ํŠธ๋ฅจ์€ ์ฒด์•ก ๊ท ํ˜•๊ณผ ์‹ ๊ฒฝ ์‹ ํ˜ธ ์ „๋‹ฌ์— ์ค‘์š”ํ•œ ์—ญํ• ์„ ํ•˜๋ฉฐ, ์ ฟ’๋‚˜ํŠธ๋ฅจํ˜ˆ์ฆ์ด ๋ฐœ์ƒํ•˜๋ฉด ์‹ ๊ฒฝ๊ณ„ ๋ฐ ๊ทผ์œก ๊ธฐ๋Šฅ์— ์‹ฌ๊ฐํ•œ ์˜ํ–ฅ์„ ๋ฏธ์น  ์ˆ˜ ์žˆ๋‹ค.
    ์ ฟ’๋‚˜ํŠธ๋ฅจํ˜ˆ์ฆ์€ ๊ธ‰์„ฑ(Acute)๊ณผ ๋งŒ์„ฑ(Chronic)์œผ๋กœ ๋‚˜๋‰˜๋ฉฐ, ๊ฒฝ๋ฏธํ•œ ๊ฒฝ์šฐ ๋ฌด์ฆ์ƒ์ผ ์ˆ˜ ์žˆ์ง€๋งŒ ์‹ฌํ•œ ๊ฒฝ์šฐ ๋‡Œ๋ถ€์ข…, ๊ฒฝ๋ จ ๋ฐ ํ˜ผ์ˆ˜ ์ƒํƒœ๋ฅผ ์ดˆ๋ž˜ํ•  ์ˆ˜ ์žˆ์–ด ์‹ ์†ํ•œ ์น˜๋ฃŒ๊ฐ€ ํ•„์š”ํ•˜๋‹ค.

    2) ์›์ธ
    ์ ฟ’๋‚˜ํŠธ๋ฅจํ˜ˆ์ฆ์€ ์ˆ˜๋ถ„ ๊ณผ๋‹ค(Water Retention), ๋‚˜ํŠธ๋ฅจ ์†์‹ค(Sodium Loss), ๋˜๋Š” ์–‘์ž์˜ ์กฐํ•ฉ์œผ๋กœ ๋ฐœ์ƒํ•œ๋‹ค.

    ์ˆ˜๋ถ„ ๊ณผ๋‹ค๋กœ ์ธํ•œ ์›์ธ
    ์‹ฌ๋ถ€์ „(Congestive Heart Failure, CHF)
    ๊ฐ„๊ฒฝํ™”(Liver Cirrhosis)
    ์‹ ์ฆํ›„๊ตฐ(Nephrotic Syndrome)
    ํ•ญ์ด๋‡จํ˜ธ๋ฅด๋ชฌ๋ถ€์ ์ ˆ๋ถ„๋น„์ฆํ›„๊ตฐ(Syndrome of Inappropriate Antidiuretic Hormone, SIADH)

    ๋‚˜ํŠธ๋ฅจ ์†์‹ค๋กœ ์ธํ•œ ์›์ธ
    ๊ตฌํ†  ๋ฐ ์„ค์‚ฌ(Vomiting & Diarrhea)
    ์ด๋‡จ์ œ ์‚ฌ์šฉ(Diuretics, ํŠนํžˆ Thiazide๊ณ„)
    ๋ถ€์‹  ๊ธฐ๋Šฅ ์ €ํ•˜(Addisonโ€™s Disease, Hypoaldosteronism)

    ํฌ์„์„ฑ ์ ฟ’๋‚˜ํŠธ๋ฅจํ˜ˆ์ฆ(Dilutional Hyponatremia)
    ๊ณผ๋„ํ•œ ์ˆ˜๋ถ„ ์„ญ์ทจ(Primary Polydipsia)
    ์ €์‚ผํˆฌ์„ฑ ์ˆ˜์•ก ํˆฌ์—ฌ(Hypotonic IV Fluids)

    3) ์ฆ์ƒ
    ์ ฟ’๋‚˜ํŠธ๋ฅจํ˜ˆ์ฆ์˜ ์ฆ์ƒ์€ ๋‚˜ํŠธ๋ฅจ ๋†๋„์™ฟ’ ๋ฐœ์ƒ ์†๋„์— ๋”ฐ๋ผ ๋‹ค๋ฅด๋ฉฐ, ์ค‘์ฆ์ผ ๊ฒฝ์šฐ ์‹ ๊ฒฝ๊ณ„ ํ•ฉ๋ณ‘์ฆ์„ ์œ ๋ฐœํ•  ์ˆ˜ ์žˆ๋‹ค.

    ์ฐธ๊ณ ์ž๋ฃŒ

    ยท Mayo Clinic. "Hyponatremia - Symptoms and Causes." Available at: https://www.mayoclinic.org
    ยท National Institutes of Health (NIH). "Hyponatremia Overview." Available at: https://www.nih.gov
    ยท American Society of Nephrology (ASN). "Electrolyte Imbalance and Hyponatremia." Available at: https://www.asn-online.org
    ยท World Health Organization (WHO). "Sodium and Health Fact Sheet." Available at: https://www.who.int
    ยท Adroguรฉ, H. J., & Madias, N. E. (2000). Hyponatremia. New England Journal of Medicine, 342(21), 1581-1589.
    ยท Sterns, R. H. (2018). Disorders of plasma sodiumโ€”causes, consequences, and correction. New England Journal of Medicine, 378(1), 55-65.
    ยท Verbalis, J. G., Goldsmith, S. R., Greenberg, A., et al. (2013). Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. American Journal of Medicine, 126(10), S1-S42.
    ยท National Kidney Foundation (NKF). (2023). Hyponatremia: Causes, Symptoms, and Treatment. Retrieved from https://www.kidney.org.
    ยท American Society of Nephrology (ASN). (2023). Sodium Disorders and Kidney Health. Retrieved from https://www.asn-online.org.
    ยท Adroguรฉ, H. J., & Madias, N. E. (2000). "Hyponatremia." New England Journal of Medicine, 342(21), 1581-1589.
    ยท Sterns, R. H. (2018). "The management of hyponatremia: Rapid correction and risks of osmotic demyelination syndrome." Kidney International Reports, 3(1), 24-35.
    ยท Verbalis, J. G., Goldsmith, S. R., Greenberg, A., Schrier, R. W., & Sterns, R. H. (2013). "Hyponatremia treatment guidelines 2013: Expert panel recommendations." American Journal of Medicine, 126(10), S1-S42.
    ยท ํ•œ๊ตญ์‹ ์žฅํ•™ํšŒ (2022). "์ ฟ’๋‚˜ํŠธ๋ฅจํ˜ˆ์ฆ์˜ ์ง„๋‹จ ๋ฐ ์น˜๋ฃŒ ๊ฐ€์ด๋“œ๋ผ์ธ."
    ยท Centers for Disease Control and Prevention (CDC). "Hyponatremia: Causes, Symptoms, and Treatment." (https://www.cdc.gov)
    ยท Mayo Clinic. "Hyponatremia โ€“ Symptoms & Causes." (https://www.mayoclinic.org)
    ยท ๋ฏธ๊ตญ ๊ตญ๋ฆฝ๋ณด๊ฑด์›(NIH), ์œ ์ „์งˆํ™˜ ์ •๋ณด๋น„๋ฐ”์นด์ง€๋…ธ Viva(GARD). "Hyponatremia Overview." (https://rarediseases.info.nih.gov)
  • Easy Ai ์š”์•ฝ

    ์ด ๋ฌธ์„œ๋Š” ์ ฟ’๋‚˜ํŠธ๋ฅจํ˜ˆ์ฆ์˜ ์ •์˜์™ฟ’ ํŠน์ง•, ์›์ธ, ์ฆ์ƒ, ์ง„๋‹จ ๋ฐฉ๋ฒ•์„ ์ž์„ธํžˆ ์„ค๋ช…ํ•˜๊ณ  ์žˆ๋‹ค. ์ ฟ’๋‚˜ํŠธ๋ฅจํ˜ˆ์ฆ์€ ์ฒด์•ก ์ฆ๊ฐ€, ์ฒด์•ก ๊ฐ์†Œ, ์ •์ƒ ์ฒด์•ก๋Ÿ‰ ์œ ์ง€ ๋“ฑ ๋‹ค์–‘ํ•œ ๊ธฐ์ „์œผ๋กœ ๋ฐœ์ƒํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‹ ๊ฒฝ๊ณ„, ์‹ฌํ˜ˆ๊ด€๊ณ„, ๋Œ€์‚ฌ ํ•ฉ๋ณ‘์ฆ์„ ์œ ๋ฐœํ•  ์ˆ˜ ์žˆ๋‹ค. ๋”ฐ๋ผ์„œ ์›์ธ์— ๋”ฐ๋ฅธ ์ ์ ˆํ•œ ์น˜๋ฃŒ์™ฟ’ ํ•จ๊ป˜ ์‹ ์†ํ•œ ๋‚˜ํŠธ๋ฅจ ๊ต์ •, ์‹ ๊ฒฝํ•™์  ๋ชจ๋‹ˆํ„ฐ๋ง, ์ˆ˜๋ถ„ ๋ฐ ์ „ํ•ด์งˆ ๊ด€๋ฆฌ, ์ƒํ™œ์Šต๊ด€ ๊ด€๋ฆฌ ๋“ฑ์˜ ํ™˜์ž ๊ฐ„ํ˜ธ ์ค‘์žฌ๊ฐ€ ์ค‘์š”ํ•˜๋‹ค. ๋˜ํ•œ ์ ฟ’๋‚˜ํŠธ๋ฅจํ˜ˆ์ฆ ํ™˜์ž์˜ ํšจ๊ณผ์ ์ธ ๊ด€๋ฆฌ๋ฅผ ์œ„ํ•ด ์‹ ์†ํ•œ ์ง„๋‹จ ๋ฐ ์น˜๋ฃŒ ์ฒด๊ณ„ ๊ตฌ์ถ•, ๋‹คํ•™์ œ์  ํ˜‘์ง„ ์ฒด๊ณ„ ํ™œ์„ฑํ™”, ์˜๋ฃŒ์ง„ ๋ฐ ํ™˜์ž ๊ต์œก ๊ฐ•ํ™”, ์‚ฌํšŒ์  ์ง€์› ํ™•๋Œ€ ๋“ฑ์ด ํ•„์š”ํ•  ๊ฒƒ์œผ๋กœ ๋ณด์ธ๋‹ค. ์ด ๋ฌธ์„œ๋Š” ์ ฟ’๋‚˜ํŠธ๋ฅจํ˜ˆ์ฆ์˜ ์ „๋ฐ˜์ ์ธ ์ดํ•ด์™ฟ’ ๊ด€๋ฆฌ์— ๋„์›€์ด ๋  ๊ฒƒ์œผ๋กœ ํŒ๋‹จ๋œ๋‹ค.
  • ์ž๋ฃŒํ›„๊ธฐ

      Ai ๋ฆฌ๋ทฐ
      ์ ฟ’๋‚˜ํŠธ๋ฅจํ˜ˆ์ฆ์˜ ์ •์˜, ์›์ธ, ์ฆ์ƒ, ์ง„๋‹จ, ์น˜๋ฃŒ ๋ฐ ๊ฐ„ํ˜ธ ์ค‘์žฌ๋ฅผ ์ข…ํ•ฉ์ ์œผ๋กœ ๋‹ค๋ฃจ๊ณ  ์žˆ์–ด ์ด ์งˆํ™˜์— ๋Œ€ํ•œ ์ „๋ฐ˜์ ์ธ ์ดํ•ด๋ฅผ ๋†’์ผ ์ˆ˜ ์žˆ๋‹ค.
    • ์ž์ฃผ๋ฌป๋Š”์งˆ๋ๅฉ์˜ ๋‹ต๋ณ€์„ ํ™•์ธํ•ด ์ฃผ์„ธ์š”

      ํ•ดํ”ผ์บ ํผ์Šค FAQ ๋”๋ต–๊ธฐ

      ๊ผญ ์•Œ์•„์ฃผ์„ธ์š”

      • ์ž๋ฃŒ์˜ ์ •๋ณด ๋ฐ ๋‚ด์šฉ์˜ ์ง„์‹ค์„ฑ์— ๋Œ€ํ•˜์—ฌ ํ•ดํ”ผ์บ ํผ์Šค๋Š” ๋ณด์ฆํ•˜์ง€ ์•Š์œผ๋ฉฐ, ํ•ด๋‹น ์ •๋ณด ๋ฐ ๊ฒŒ์‹œ๋ฌผ ์ €์ž‘๊ถŒ๊ณผ ๊ธฐํƒ€ ๋ฒ•์  ์ฑ…์ž„์€ ์ž๋ฃŒ ๋“ฑ๋ก์ž์—๊ฒŒ ์žˆ์Šต๋‹ˆ๋‹ค.
        ์ž๋ฃŒ ๋ฐ ๊ฒŒ์‹œ๋ฌผ ๋‚ด์šฉ์˜ ๋ถˆ๋ฒ•์  ์ด์šฉ, ๋ฌด๋‹จ ์ „์žฌโˆ™๋ฐฐํฌ๋Š” ๊ธˆ์ง€๋˜์–ด ์žˆ์Šต๋‹ˆ๋‹ค.
        ์ €์ž‘๊ถŒ์นจํ•ด, ๋ช…์˜ˆํ›ผ์† ๋“ฑ ๋ถ„์Ÿ ์š”์†Œ ๋ฐœ๊ฒฌ ์‹œ ๊ณ ๊ฐ๋น„๋ฐ”์นด์ง€๋…ธ Viva์˜ ์ €์ž‘๊ถŒ์นจํ•ด ์‹ ๊ณ ๋น„๋ฐ”์นด์ง€๋…ธ Viva๋ฅผ ์ด์šฉํ•ด ์ฃผ์‹œ๊ธฐ ๋ฐ”๋ž๋‹ˆ๋‹ค.
      • ํ•ดํ”ผ์บ ํผ์Šค๋Š” ๊ตฌ๋งค์ž์™ฟ’ ํŒ๋งค์ž ๋ชจ๋‘๊ฐ€ ๋งŒ์กฑํ•˜๋Š” ์„œ๋น„์Šค๊ฐ€ ๋˜๋„๋ก ๋…ธ๋ ฅํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ์•„๋ž˜์˜ 4๊ฐ€์ง€ ์ž๋ฃŒํ™˜๋ถˆ ์กฐ๊ฑด์„ ๊ผญ ํ™•์ธํ•ด์ฃผ์‹œ๊ธฐ ๋ฐ”๋ž๋‹ˆ๋‹ค.
        ํŒŒ์ผ์˜ค๋ฅ˜ ์ค‘๋ณต์ž๋ฃŒ ์ €์ž‘๊ถŒ ์—†์Œ ์„ค๋ช…๊ณผ ์‹ค์ œ ๋‚ด์šฉ ๋ถˆ์ผ์น˜
        ํŒŒ์ผ์˜ ๋‹ค์šด๋กœ๋“œ๊ฐ€ ์ œ๋Œ€๋กœ ๋˜์ง€ ์•Š๊ฑฐ๋‚˜ ํŒŒ์ผํ˜•์‹์— ๋งž๋Š” ํ”„๋กœ๊ทธ๋žจ์œผ๋กœ ์ •์ƒ ์ž‘๋™ํ•˜์ง€ ์•Š๋Š” ๊ฒฝ์šฐ ๋‹ค๋ฅธ ์ž๋ฃŒ์™ฟ’ 70% ์ด์ƒ ๋‚ด์šฉ์ด ์ผ์น˜ํ•˜๋Š” ๊ฒฝ์šฐ (์ค‘๋ณต์ž„์„ ํ™•์ธํ•  ์ˆ˜ ์žˆ๋Š” ๊ทผ๊ฑฐ ํ•„์š”ํ•จ) ์ธํ„ฐ๋„ท์˜ ๋‹ค๋ฅธ ์‚ฌ์ดํŠธ, ์—ฐ๊ตฌ๊ธฐ๊ด€, ํ•™๊ป“, ์„œ์  ๋“ฑ์˜ ์ž๋ฃŒ๋ฅผ ๋„์šฉํ•œ ๊ฒฝ์šฐ ์ž๋ฃŒ์˜ ์„ค๋ช…๊ณผ ์‹ค์ œ ์ž๋ฃŒ์˜ ๋‚ด์šฉ์ด ์ผ์น˜ํ•˜์ง€ ์•Š๋Š” ๊ฒฝ์šฐ

    ์ฐพ์œผ์‹œ๋˜ ์ž๋ฃŒ๊ฐ€ ์•„๋‹Œ๊ฐ€์š”?

    ์ง€๊ธˆ ๋ณด๋Š” ์ž๋ฃŒ์™ฟ’ ์—ฐ๊ด€๋˜์–ด ์žˆ์–ด์š”!
    ์™ผ์ชฝ ํ™”์‚ดํ‘œ
    ์˜ค๋ฅธ์ชฝ ํ™”์‚ดํ‘œ
    ํŒ๋งค์ž ์„ค์ •ํ‘œ์่ง
    ๋ฌธ์„œ ์ดˆ์•ˆ์„ ์ƒ์„ฑํ•ด์ฃผ๋Š” EasyAI
    ์•ˆ๋…•ํ•˜์„ธ์š”. ํ•ดํ”ผ์บ ํผ์Šค์˜ ๋ฐฉ๋Œ€ํ•œ ์ž๋ฃŒ ์ค‘์—์„œ ์„ ๋ณ„ํ•˜์—ฌ ๋‹น์‹ ๋งŒ์˜ ์ดˆ์•ˆ์„ ๋งŒ๋“ค์–ด์ฃผ๋Š” EasyAI ์ž…๋‹ˆ๋‹ค.
    ์ €๋Š” ์•„๋ž˜์™ฟ’ ๊ฐ™์ด ์ž‘์—…์„ ๋„์™ฟ’๋“œ๋ฆฝ๋‹ˆ๋‹ค.
    - ์ฃผ์ œ๋งŒ ์ž…๋ ฅํ•˜๋ฉด ๋ชฉ์ฐจ๋ถ€ํ„ฐ ๋ณธ๋ๅฉ๋‚ด์šฉ๊นŒ์ง€ ์ž๋™ ์ƒ์„ฑํ•ด ๋“œ๋ฆฝ๋‹ˆ๋‹ค.
    - ์žฅ๋ฌธ์˜ ์ฝ˜ํ…์ธ ๋ฅผ ์‰ฝ๊ณ  ๋น ๋ฅด๊ฒŒ ์ž‘์„ฑํ•ด ๋“œ๋ฆฝ๋‹ˆ๋‹ค.
    - ์Šคํ† ์–ด์—์„œ ๋ฌด๋ฃŒ ์บ์‹œ๋ฅผ ๊ณ„์ •๋ณ„๋กœ 1ํšŒ ๋ฐœ๊ธ‰ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ์ง€๊ธˆ ๋ฐ”๋กœ ์ฒดํ—˜ํ•ด ๋ณด์„ธ์š”!
    ์ด๋Ÿฐ ์ฃผ์ œ๋“ค์„ ์ž…๋ ฅํ•ด ๋ณด์„ธ์š”.
    - ์œ ์•„์—๊ฒŒ ์ ํ•ฉํ•œ ๋ฌธํ•™์ž‘ํ’ˆ์˜ ๊ธฐ์ค€๊ณผ ํŠน์„ฑ
    - ํ•œ๊ตญ์ธ์˜ ๊ฐ€์น˜๊ด€ ์ค‘์—์„œ ์ •์‹ ์  ๊ฐ€์น˜๊ด€์„ ์ด๋ฃจ๋Š” ๊ฒƒ๋“ค์„ ๋ฌธํ™”์  ๋ฌธ๋ฒ•์œผ๋กœ ์ •๋ฆฌํ•˜๊ณ , ํ˜„๋Œ€ํ•œ๊ตญ์‚ฌํšŒ์—์„œ ์ผ์–ด๋‚˜๋Š” ์‚ฌ๊ฑด๊ณผ ์‚ฌ๊ณ ๋ฅผ ๋น„๊ตํ•˜์—ฌ ์ž์‹ ์˜ ์˜๊ฒฌ์œผ๋กœ ๊ธฐ์ˆ ํ•˜์„ธ์š”
    - ์ž‘๋ณ„์ธ์‚ฌ ๋…ํ›„๊ฐ
    ํ•ด์บ  AI ์ฑ—๋ด‡๊ณผ ๋Œ€ํ™”ํ•˜๊ธฐ
    ์ฑ—๋ด‡์œผ๋กœ ๊ฐ„ํŽธํ•˜๊ฒŒ ์ƒ๋‹ดํ•ด๋ณด์„ธ์š”.
    2025๋…„ 06์›” 14์ผ ํ† ์š”์ผ
    AI ์ฑ—๋ด‡
    ์•ˆ๋…•ํ•˜์„ธ์š”. ํ•ดํ”ผ์บ ํผ์Šค AI ์ฑ—๋ด‡์ž…๋‹ˆ๋‹ค. ๋ฌด์—‡์ด ๊ถ๊ธˆํ•˜์‹ ๊ฐ€์š”?
    6:41 ์˜คํ›„